phenotypeId,webApiCohortId,cohortName,logicDescription,cohortId,referentConceptId,cohortType,PMID
4164770000,18649,Fishers syndrome referent incident cohort,"Persons with condition occurrence of referent concept (4070552) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4070552001,4070552,referent,
4164770000,18648,Fishers syndrome referent prevalent cohort,"Persons with condition occurrence of referent concept (4070552) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4070552002,4070552,referent,
4164770000,18653,Guillain-Barré syndrome referent incident cohort,"Persons with condition occurrence of referent concept (4164770) or descendants, for the first time in the person's history. Persons exit cohort at the end of the observation period.",4164770001,4164770,referent,
4164770000,18652,Guillain-Barré syndrome referent prevalent cohort,"Persons with condition occurrence of referent concept (4164770) or descendants, for the first time in the person's history, with at least 365 days of prior continuous observation. Persons exit cohort at the end of the observation period.",4164770002,4164770,referent,
4164770000,18478,"Guillain-Barre syndrome inpatient (Arya et al, ScallenWalter et al, Iqbal et al, Anandan et al, Rasmussen et al. Baxter et al.)",,4164770003,4164770,literature,
4164770000,20054,FDA AESI Guillain Barre syndrome events,All events of GB syndrome (includes Fisher syndrome) with no events in prior clean period (365 days). No continuous observation period requirement. Persons exit the cohort on start_date + 1 day. Note - Acute infective polyneuritis code was used to capture GB syndrome in ICD9CM.,4164770004,4164770,study;FDA;Covid,
4164770000,20057,FDA AESI Guillain Barre syndrome IP primary events,"All primary diagnosis events of GB syndrome (includes Fisher syndrome) limited to overlapping inpatient visit, with no such events in prior clean period (365 days). No continuous observation period requirement. Persons exit the cohort on start_date + 1 day. Note - Acute infective polyneuritis code was used to capture GB syndrome in ICD9CM.",4164770005,4164770,study;FDA;Covid,
4164770000,20058,FDA AESI Guillain Barre syndrome IP primary event episodes for incidence characterization,All primary diagnosis events of GB syndrome (includes Fisher syndrome) limited to overlapping inpatient visit. No continuous observation period requirement. Persons exit the cohort on start_date + 365 days. Note - Acute infective polyneuritis code was used to capture GB syndrome in ICD9CM.,4164770006,4164770,study;FDA;Covid,
4164770000,20059,FDA AESI Guillain Barre syndrome event episodes for incidence characterization,All events of GB syndrome (includes Fisher syndrome) with no events in prior clean period (365 days). No continuous observation period requirement. Persons exit the cohort on start_date + 365 days. Note - Acute infective polyneuritis code was used to capture GB syndrome in ICD9CM.,4164770007,4164770,study;FDA;Covid,
4164770000,20068,FDA AESI Guillain Barre syndrome IP events,"All any diagnosis events of GB syndrome (includes Fisher syndrome) limited to overlapping inpatient visit, with no such events in prior clean period (365 days). No continuous observation period requirement. Persons exit the cohort on start_date + 1 day. Note - Acute infective polyneuritis code was used to capture GB syndrome in ICD9CM.",4164770008,4164770,study;FDA;Covid,
4164770000,20069,FDA AESI Guillain Barre syndrome IP event episodes for incidence characterization,All any diagnosis events of GB syndrome (includes Fisher syndrome) limited to overlapping inpatient visit. No continuous observation period requirement. Persons exit the cohort on start_date + 365 days. Note - Acute infective polyneuritis code was used to capture GB syndrome in ICD9CM.,4164770009,4164770,study;FDA;Covid,
